| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca74ed15eb9426695541087e53bd9e00 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4354 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K4-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-03 |
| filingDate |
2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e89b085221df861c82581bf2c466518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5b88c60ad1b0724ac2e868deb64f3d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef8277e18c514ecaa3bdefce303f0920
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1f3a68a0b781204315c3ebbe76f035c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba6ba9e03791266700e9bbfc292f081a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c8e6ae538ed086eb94c0fc8dc995eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf124aa0467194f34941724e9247548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64299a45ec2e197f867f4d4312519782 |
| publicationDate |
2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102241734-B |
| titleOfInvention |
Anticoagulation polypeptide and application thereof |
| abstract |
The invention relates to an anticoagulation polypeptide and application thereof, belonging to the field of biomedicines. The polypeptide is composed of an amino acid sequence shown as SEQ ID NO.1, is formed by substituting, deleting or adding one or several amino acid residues on the amino acid sequence shown as SEQ ID NO.1 and is a derivative peptide capable of selectively inhibiting a blood coagulation factor XIa. The anticoagulation polypeptide is a selective depressant of the blood coagulation factor XIa, has stronger anticoagulation activity, can obviously prolong activated partial thromboplastin time during plasma activation and basically has no influence on prothrombin time. The anticoagulation polypeptide has a stronger anti-thrombosis effect, can be used as medicines used for preventing and treating thromboembolic diseases and has less side effect. |
| priorityDate |
2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |